Patient advocacy organizations supply knowledge and funds to combat illness and disease. But their boardrooms and executive suites are often full of people with ties to the drug industry, a new study shows. In a research letter on patient advocacy organizations (PAO’s) by the American Medical Association published in JAMA Internal Medicine, the authors found: […]